BERKELEY, Calif., Jan. 18, 2008 (PRIME NEWSWIRE) -- XOMA Ltd. (Nasdaq:XOMA), a leader in the discovery and development of antibody therapeutics, announced today that its Board of Directors has appointed current board member W. Denman (“Denny”) Van Ness as Lead Independent Director.
